Healthcare Finance News December 19, 2024
Jeff Lagasse

CMS says the excess costs of the program were “unprecedented” in CMS Innovation Center models.

The Centers for Medicare and Medicaid Services is terminating the Medicare Advantage Value-Based Insurance Design (VBID) model at the end of 2025 due to what it called the model’s “substantial and unmitigable costs to the Medicare Trust Funds.”

These excess costs totaled $2.3 billion in Calendar Year 2021 and $2.2 billion in CY 2022. These costs were associated with the VBID model, based on the prior and forthcoming evaluation reports, and CMS described them as “unprecedented” in CMS Innovation Center models.

Performance analyses of the model, according to CMS, showed the costs were driven in part by increased risk score growth and Part D expenditures,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage, Payment Models, Provider, Value Based
An Introduction to MIPS Basics
How Healthcare Leaders Reacted to the 15 Additional Drugs Selected for Medicare Negotiation Program
Lawmakers, experts weigh in on Medicare Drug Price Negotiation Program
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals

Share This Article